Literature DB >> 3480536

Induction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein.

B Dietzschold1, H H Wang, C E Rupprecht, E Celis, M Tollis, H Ertl, E Heber-Katz, H Koprowski.   

Abstract

We have studied the ability of rabies virus ribonucleoprotein (RNP) to induce a protective immune response in animals against lethal challenge with rabies and rabies-related lyssa viruses. Liposomes containing either RNP or the glycoprotein (G protein) of a variant virus with multiple alterations in the G antigenic structure conferred no or poor protection, respectively, against lethal intracerebral challenge with rabies virus. By contrast, liposomes containing RNP and the variant G protein induced a good protective response, comparable to that achieved with inactivated virus vaccine against intracerebral challenge. Moreover, mice or raccoons immunized with RNP alone resisted lethal peripheral challenge with homologous or heterologous virus strains. These results indicate that the RNP of rabies virus plays a crucial role in induction of protective immunity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3480536      PMCID: PMC299713          DOI: 10.1073/pnas.84.24.9165

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  T cells primed by influenza virion internal components can cooperate in the antibody response to haemagglutinin.

Authors:  S M Russell; F Y Liew
Journal:  Nature       Date:  1979-07-12       Impact factor: 49.962

2.  Rabies group-specific ribonucleoprotein antigen and a test system for grouping and typing of rhabdoviruses.

Authors:  L G Schneider; B Dietzschold; R E Dierks; W Matthaeus; P J Enzmann; K Strohmaier
Journal:  J Virol       Date:  1973-05       Impact factor: 5.103

3.  Laboratory techniques in rabies. Mouse inoculation test.

Authors:  H Koprowski
Journal:  Monogr Ser World Health Organ       Date:  1966

4.  Induction and biological properties of defective interfering particles of rabies virus.

Authors:  T J Wiktor; B Dietzschold; R N Leamnson; H Koprowski
Journal:  J Virol       Date:  1977-02       Impact factor: 5.103

5.  Isolation and purification of a polymeric form of the glycoprotein of rabies virus.

Authors:  B Dietzschold; J H Cox; L G Schneider; T J Wiktor; H Koprowski
Journal:  J Gen Virol       Date:  1978-07       Impact factor: 3.891

6.  Immunogenicity of a synthetic HBsAg peptide: enhancement by conjugation to a fatty acid carrier.

Authors:  T P Hopp
Journal:  Mol Immunol       Date:  1984-01       Impact factor: 4.407

7.  Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene.

Authors:  T J Wiktor; R I Macfarlan; K J Reagan; B Dietzschold; P J Curtis; W H Wunner; M P Kieny; R Lathe; J P Lecocq; M Mackett
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

8.  Rabies virus glycoprotein. II. Biological and serological characterization.

Authors:  J H Cox; B Dietzschold; L G Schneider
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

9.  The S segment of the Germiston virus RNA genome can code for three proteins.

Authors:  S Gerbaud; P Vialat; N Pardigon; C Wychowski; M Girard; M Bouloy
Journal:  Virus Res       Date:  1987-07       Impact factor: 3.303

10.  Protection against hepatitis B virus infection by immunization with hepatitis B core antigen.

Authors:  S Iwarson; E Tabor; H C Thomas; P Snoy; R J Gerety
Journal:  Gastroenterology       Date:  1985-03       Impact factor: 22.682

View more
  54 in total

1.  Conserved nucleotide sequence of rabies virus cDNA encoding the nucleoprotein.

Authors:  K Mannen; K Hiramatsu; K Mifune; S Sakamoto
Journal:  Virus Genes       Date:  1991-01       Impact factor: 2.332

2.  Raccoon poxvirus recombinants expressing the rabies virus nucleoprotein protect mice against lethal rabies virus infection.

Authors:  D L Lodmell; J W Sumner; J J Esposito; W J Bellini; L C Ewalt
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

3.  Could the homologous sequence of anti-inflammatory pentapeptide (MLIF) produced by Entamoeba histolytica in the N protein of rabies virus affect the inflammatory process?

Authors:  M E Morales; G Rico; J L Gómez; R Alonso; R Cortés; R Silva; J A Giménez; R Kretschmer; A Aguilar-Setién
Journal:  Parasitol Res       Date:  2005-12-10       Impact factor: 2.289

4.  Identification of an immunodominant epitope within the phosphoprotein of rabies virus that is recognized by both class I- and class II-restricted T cells.

Authors:  J K Larson; W H Wunner; L Otvos; H C Ertl
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

5.  Bacterially expressed nucleoprotein of infectious hematopoietic necrosis virus augments protective immunity induced by the glycoprotein vaccine in fish.

Authors:  L A Oberg; J Wirkkula; D Mourich; J C Leong
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

6.  Nucleocapsid of rabies virus improve immune response of an inactivated avian influenza vaccine.

Authors:  Elizabeth Loza-Rubio; Juan Molina-Güarneros; Juan Antonio Montaño-Hirose
Journal:  Vet Res Commun       Date:  2009-01-31       Impact factor: 2.459

7.  Molecular characterization of the full-length genome of a rabies virus isolate from India.

Authors:  Tirumuru Nagaraja; Shampur Madhusudana; Anita Desai
Journal:  Virus Genes       Date:  2008-03-25       Impact factor: 2.332

Review 8.  Gene vaccination for hepatitis C.

Authors:  G Inchauspé
Journal:  Springer Semin Immunopathol       Date:  1997

9.  Differential ability of B cells specific for external vs. internal influenza virus proteins to respond to help from influenza virus-specific T-cell clones in vivo.

Authors:  P A Scherle; W Gerhard
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

10.  MHC class II-restricted T-cell hybridomas recognizing the nucleocapsid protein of avian coronavirus IBV.

Authors:  A M Boots; M J Van Lierop; J G Kusters; P J Van Kooten; B A Van der Zeijst; E J Hensen
Journal:  Immunology       Date:  1991-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.